Boundless Bio, Inc. (BOLD) vs MiNK Therapeutics, Inc. (INKT)

A side-by-side comparison of Boundless Bio, Inc. and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Boundless Bio, Inc. logo
BOLD
Boundless Bio, Inc.
$58M
$2.56HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
$59M
$11.84HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

Total return — BOLD vs INKT

growth of $100 · dividends reinvested · last 3y
BOLD -81.8% (-43.3%/yr)INKT +34.1% (+10.3%/yr)INKT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$18$134
BOLD INKT

BOLD vs INKT: by the numbers

  • •INKT is the larger company ($59M vs $58M market cap).

Metrics side by side

Valuation

MetricBOLDINKT
P/B ratio0.87N/A

Profitability

MetricBOLDINKT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-58.99%N/A
ROIC-43.97%-604.20%

Go deeper

Full BOLD analysisFull INKT analysisInteractive comparison tool

Dig into the metrics

Boundless Bio ROEMiNK Therapeutics ROEBoundless Bio operating marginMiNK Therapeutics operating marginBoundless Bio revenue growthMiNK Therapeutics revenue growthBoundless Bio free cash flowMiNK Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.